All lobbying filings

FEROX STRATEGIES

Lobbying for VIATRIS INC · Pharmaceutical company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Income

$70,000.00

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 6

Commerce, Dept of (DOC)
Executive Office of the President (EOP)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
U.S. Trade Representative (USTR)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Pharmacy

Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations.

Foreign Relations

Issues related to PEPFAR.

Trade (domestic/foreign)

ITrade issues related to generic medicines.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.